Tapewire

Nasdaq · USD

NBIX

NEUROCRINE BIOSCIENCES INC

Export transactions ↓
Tapewire entity
2655
SEC CIK
0000914475
Parsed reports
676

Last 12 months

Inside the activity.

0 purchase rows · 40 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202504
Jan 202602
Feb 202600
Mar 202600
Apr 202600
May 202606
Jun 2026015
Jul 202606
Aug 202600
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 07, 2018 Filed Nov 8, 2018 22:03 UTC
Lloyd-Smith MalcolmChief Regulatory Officer
SaleCommon Stock 3,300 $110.00 $363,000.00
Disclosure

SEC source: 0001209191-18-057771 · doc4.xml · nonDerivative · entry 4

Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,318

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Read SEC document
November 07, 2018 Filed Nov 8, 2018 22:03 UTC
Lloyd-Smith MalcolmChief Regulatory Officer
Exercise / conversionCommon Stock 3,300 $15.45 $50,985.00
Disclosure

SEC source: 0001209191-18-057771 · doc4.xml · nonDerivative · entry 3

Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 15,046 $8.66 Strike: $8.66 $130,298.36
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · derivative · entry 12

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,048

Underlying: Common Stock · 15,046 shares

Expires 2022-01-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Option granted January 12, 2012 and vested monthly over four years.

Read SEC document
November 07, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 9,122 $5.76 Strike: $5.76 $52,542.72
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · derivative · entry 11

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,121

Underlying: Common Stock · 9,122 shares

Expires 2021-08-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Option granted August 25, 2011 and vested monthly over four years.

Read SEC document
November 07, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 5,231 $35.99 Strike: $35.99 $188,263.69
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · derivative · entry 10

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,533

Underlying: Common Stock · 5,231 shares

Expires 2026-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Option granted February 05, 2016 and vested monthly over four years.

Read SEC document
November 07, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
SaleCommon Stock 15,046 $110.26 $1,659,014.09
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · nonDerivative · entry 8

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,997

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F3 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $110.08 to $110.90. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
November 07, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
Exercise / conversionCommon Stock 15,046 $8.66 $130,298.36
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · nonDerivative · entry 7

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,043

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
SaleCommon Stock 9,122 $110.03 $1,003,708.26
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · nonDerivative · entry 6

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,997

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $110.00 to $110.08. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
November 07, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
Exercise / conversionCommon Stock 9,122 $5.76 $52,542.72
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · nonDerivative · entry 5

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,119

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 07, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
SaleCommon Stock 5,231 $110.00 $575,410.00
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · nonDerivative · entry 4

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,997

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Read SEC document
November 07, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
Exercise / conversionCommon Stock 5,231 $35.99 $188,263.69
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · nonDerivative · entry 3

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,228

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 06, 2018 Filed Nov 8, 2018 22:03 UTC
Lloyd-Smith MalcolmChief Regulatory Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 5,700 $15.45 Strike: $15.45 $88,065.00
Disclosure

SEC source: 0001209191-18-057771 · doc4.xml · derivative · entry 5

Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,256

Underlying: Common Stock · 5,700 shares

Expires 2024-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option granted October 1, 2014 and vested 25% upon first anniversary (October 1, 2015) and remaining 75% vested in 36 equal monthly installments beginning November 1, 2015.

Read SEC document
November 06, 2018 Filed Nov 8, 2018 22:03 UTC
Lloyd-Smith MalcolmChief Regulatory Officer
SaleCommon Stock 5,700 $110.02 $627,095.76
Disclosure

SEC source: 0001209191-18-057771 · doc4.xml · nonDerivative · entry 2

Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,318

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Read SEC document
November 06, 2018 Filed Nov 8, 2018 22:03 UTC
Lloyd-Smith MalcolmChief Regulatory Officer
Exercise / conversionCommon Stock 5,700 $15.45 $88,065.00
Disclosure

SEC source: 0001209191-18-057771 · doc4.xml · nonDerivative · entry 1

Lloyd-Smith Malcolm · CIK 0001557146 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,018

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 06, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 9,420 $35.99 Strike: $35.99 $339,025.80
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · derivative · entry 9

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,764

Underlying: Common Stock · 9,420 shares

Expires 2026-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Option granted February 05, 2016 and vested monthly over four years.

Read SEC document
November 06, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
SaleCommon Stock 9,420 $110.10 $1,037,167.43
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · nonDerivative · entry 2

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,997

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Read SEC document
November 06, 2018 Filed Nov 8, 2018 22:04 UTC
Bozigian Haig P.Chief Development Officer
Exercise / conversionCommon Stock 9,420 $35.99 $339,025.80
Disclosure

SEC source: 0001209191-18-057772 · doc4.xml · nonDerivative · entry 1

Bozigian Haig P. · CIK 0001423837 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 02, 2018 Filed Nov 5, 2018 21:11 UTC
LYONS GARY ADirector
SaleCommon Stock 15,000 $114.41 $1,716,213.00
Disclosure

SEC source: 0001209191-18-057150 · doc4.xml · nonDerivative · entry 1

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 245,697

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $112.09 to $116.24. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
October 29, 2018 Filed Oct 30, 2018 21:58 UTC SaleCommon Stock 5,500 $107.13 $589,237.00
Disclosure

SEC source: 0001209191-18-056550 · doc4.xml · nonDerivative · entry 1

POPS RICHARD F · CIK 0001126490 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,759

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $103.50 to $109.51. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 00:41 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionIncentive Stock Option · Derivative 2,102 $32.99 Strike: $32.99 $69,344.98
Disclosure

SEC source: 0001209191-18-049721 · doc4.xml · derivative · entry 8

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,710

Underlying: Common Stock · 2,102 shares

Expires 2025-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Option granted February 3, 2015 and vests monthly over four years.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 00:41 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionIncentive Stock Option · Derivative 5,978 $19.59 Strike: $19.59 $117,109.02
Disclosure

SEC source: 0001209191-18-049721 · doc4.xml · derivative · entry 7

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,978 shares

Expires 2024-01-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option granted January 16, 2014 and vested monthly over four years.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 00:41 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionIncentive Stock Option · Derivative 11,037 $8.65 Strike: $8.65 $95,470.05
Disclosure

SEC source: 0001209191-18-049721 · doc4.xml · derivative · entry 6

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,037 shares

Expires 2023-01-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option granted January 10, 2013 and vested monthly over four years.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 00:41 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionIncentive Stock Option · Derivative 13,632 $8.66 Strike: $8.66 $118,053.12
Disclosure

SEC source: 0001209191-18-049721 · doc4.xml · derivative · entry 5

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,632 shares

Expires 2022-01-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Option granted January 12, 2012 and vested monthly over four years.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 00:41 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionCommon Stock 2,102 $32.99 $69,344.98
Disclosure

SEC source: 0001209191-18-049721 · doc4.xml · nonDerivative · entry 4

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,691

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 00:41 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionCommon Stock 5,978 $19.59 $117,109.02
Disclosure

SEC source: 0001209191-18-049721 · doc4.xml · nonDerivative · entry 3

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,589

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 00:41 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionCommon Stock 11,037 $8.65 $95,470.05
Disclosure

SEC source: 0001209191-18-049721 · doc4.xml · nonDerivative · entry 2

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,611

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 00:41 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionCommon Stock 13,632 $8.66 $118,053.12
Disclosure

SEC source: 0001209191-18-049721 · doc4.xml · nonDerivative · entry 1

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,574

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 20:08 UTC
Gano KyleChief Business Development Off
Exercise / conversionNon-Qualified Stock Option · Derivative 28,266 $8.66 Strike: $8.66 $244,783.56
Disclosure

SEC source: 0001209191-18-045265 · doc4.xml · derivative · entry 3

Gano Kyle · CIK 0001567160 · Chief Business Development Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,266

Underlying: Common Stock · 28,266 shares

Expires 2022-01-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option granted January 12, 2012 and vested monthly over four years.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 20:08 UTC
Gano KyleChief Business Development Off
SaleCommon Stock 28,266 $115.00 $3,250,590.00
Disclosure

SEC source: 0001209191-18-045265 · doc4.xml · nonDerivative · entry 2

Gano Kyle · CIK 0001567160 · Chief Business Development Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,742

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 20:08 UTC
Gano KyleChief Business Development Off
Exercise / conversionCommon Stock 28,266 $8.66 $244,783.56
Disclosure

SEC source: 0001209191-18-045265 · doc4.xml · nonDerivative · entry 1

Gano Kyle · CIK 0001567160 · Chief Business Development Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 20:07 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 23,022 $19.59 Strike: $19.59 $451,000.98
Disclosure

SEC source: 0001209191-18-045264 · doc4.xml · derivative · entry 3

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,022 shares

Expires 2024-01-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option granted January 6, 2014 and vested monthly over four years.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 20:07 UTC
Grigoriadis Dimitri E.Chief Research Officer
SaleCommon Stock 23,022 $110.00 $2,532,420.00
Disclosure

SEC source: 0001209191-18-045264 · doc4.xml · nonDerivative · entry 2

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,942

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Read SEC document
August 01, 2018 Filed Aug 3, 2018 20:07 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionCommon Stock 23,022 $19.59 $451,000.98
Disclosure

SEC source: 0001209191-18-045264 · doc4.xml · nonDerivative · entry 1

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 28, 2018 Filed Jun 29, 2018 23:32 UTC
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
Exercise / conversionIncentive Stock Option · Derivative 864 $32.99 Strike: $32.99 $28,503.36
Disclosure

SEC source: 0001209191-18-040121 · doc4.xml · derivative · entry 10

GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,031

Underlying: Common Stock · 864 shares

Expires 2025-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option vested on March 3, 2015 and an additional 1/48th of the shares underlying the option vested each month thereafter.

Read SEC document
June 28, 2018 Filed Jun 29, 2018 23:32 UTC
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
Exercise / conversionIncentive Stock Option · Derivative 7,142 $19.59 Strike: $19.59 $139,911.78
Disclosure

SEC source: 0001209191-18-040121 · doc4.xml · derivative · entry 9

GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,142 shares

Expires 2024-01-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option vested on February 16, 2014 and an additional 1/48th of the shares underlying the option vested each month thereafter.

Read SEC document
June 28, 2018 Filed Jun 29, 2018 23:32 UTC
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
Exercise / conversionIncentive Stock Option · Derivative 10,199 $8.65 Strike: $8.65 $88,221.35
Disclosure

SEC source: 0001209191-18-040121 · doc4.xml · derivative · entry 8

GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,199 shares

Expires 2023-01-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option vested on February 10, 2013 and an additional 1/48th of the shares underlying the option vested each month thereafter.

Read SEC document
June 28, 2018 Filed Jun 29, 2018 23:32 UTC
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
Exercise / conversionIncentive Stock Option · Derivative 16,551 $8.66 Strike: $8.66 $143,331.66
Disclosure

SEC source: 0001209191-18-040121 · doc4.xml · derivative · entry 7

GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,551 shares

Expires 2022-01-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Represents option of which 1/48th of the shares underlying the option vested on February 12, 2012 and an additional 1/48th of the shares underlying the option vested each month thereafter.

Read SEC document
June 28, 2018 Filed Jun 29, 2018 23:32 UTC
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
Exercise / conversionIncentive Stock Option · Derivative 23,168 $5.76 Strike: $5.76 $133,447.68
Disclosure

SEC source: 0001209191-18-040121 · doc4.xml · derivative · entry 6

GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,168 shares

Expires 2021-08-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Represents option of which 1/36th of the shares underlying the option vested on September 25, 2011 and an additional 1/36th of the shares underlying the option vested each month thereafter.

Read SEC document
June 28, 2018 Filed Jun 29, 2018 23:32 UTC
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 864 $32.99 $28,503.36
Disclosure

SEC source: 0001209191-18-040121 · doc4.xml · nonDerivative · entry 5

GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 404,957

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 28, 2018 Filed Jun 29, 2018 23:32 UTC
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 7,142 $19.59 $139,911.78
Disclosure

SEC source: 0001209191-18-040121 · doc4.xml · nonDerivative · entry 4

GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 404,093

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 28, 2018 Filed Jun 29, 2018 23:32 UTC
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,199 $8.65 $88,221.35
Disclosure

SEC source: 0001209191-18-040121 · doc4.xml · nonDerivative · entry 3

GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 396,951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 28, 2018 Filed Jun 29, 2018 23:32 UTC
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 16,551 $8.66 $143,331.66
Disclosure

SEC source: 0001209191-18-040121 · doc4.xml · nonDerivative · entry 2

GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 386,752

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 28, 2018 Filed Jun 29, 2018 23:32 UTC
GORMAN KEVIN CHARLESDirector · Chief Executive Officer
Exercise / conversionCommon Stock 23,168 $5.76 $133,447.68
Disclosure

SEC source: 0001209191-18-040121 · doc4.xml · nonDerivative · entry 1

GORMAN KEVIN CHARLES · CIK 0001201096 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370,201

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 20, 2018 Filed Jun 21, 2018 22:16 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 23,000 $19.59 Strike: $19.59 $450,570.00
Disclosure

SEC source: 0001209191-18-039022 · doc4.xml · derivative · entry 3

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,022

Underlying: Common Stock · 23,000 shares

Expires 2024-01-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Represents option which vested 1/4 upon anniversary of grant (1/16/2015), thereafter vested in equal monthly installments over the following three years such that the entire award was fully vested at 12/16/2017.

Read SEC document
June 20, 2018 Filed Jun 21, 2018 22:16 UTC
Grigoriadis Dimitri E.Chief Research Officer
SaleCommon Stock 23,000 $105.00 $2,415,000.00
Disclosure

SEC source: 0001209191-18-039022 · doc4.xml · nonDerivative · entry 2

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,942

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Read SEC document
June 20, 2018 Filed Jun 21, 2018 22:16 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionCommon Stock 23,000 $19.59 $450,570.00
Disclosure

SEC source: 0001209191-18-039022 · doc4.xml · nonDerivative · entry 1

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,942

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 14, 2018 Filed Jun 15, 2018 20:44 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionNon-Qualified Stock Option · Derivative 23,000 $19.59 Strike: $19.59 $450,570.00
Disclosure

SEC source: 0001209191-18-038093 · doc4.xml · derivative · entry 8

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,022

Underlying: Common Stock · 23,000 shares

Expires 2024-01-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Represents option which vests 1/4 upon anniversary of grant (1/16/2015), thereafter vesting in equal monthly installments over the following three years such that the entire award is fully vested at 12/16/2017.

Read SEC document
June 14, 2018 Filed Jun 15, 2018 20:44 UTC
Grigoriadis Dimitri E.Chief Research Officer
SaleCommon Stock 2,785 $100.00 $278,500.00
Disclosure

SEC source: 0001209191-18-038093 · doc4.xml · nonDerivative · entry 6

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,942

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.

Read SEC document
June 14, 2018 Filed Jun 15, 2018 20:44 UTC
Grigoriadis Dimitri E.Chief Research Officer
Exercise / conversionCommon Stock 2,785 $19.59 $54,558.15
Disclosure

SEC source: 0001209191-18-038093 · doc4.xml · nonDerivative · entry 5

Grigoriadis Dimitri E. · CIK 0001423838 · Chief Research Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,727

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 20:45 UTC
LYONS GARY ADirector
SaleCommon Stock 15,000 $99.24 $1,488,549.00
Disclosure

SEC source: 0001209191-18-038096 · doc4.xml · nonDerivative · entry 1

LYONS GARY A · CIK 0001123343 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,697

F1 · kind: The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 2 above.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $97.95 to $100.33. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.